Cough: an unmet clinical need
- PMID: 21198555
- PMCID: PMC3085873
- DOI: 10.1111/j.1476-5381.2010.01198.x
Cough: an unmet clinical need
Abstract
Cough is among the most common complaints for which patients worldwide seek medical attention. Thus, the evaluation and treatment of cough result in tremendous financial expenditure and consumption of health care resources. Yet, despite the clinical significance of cough, research efforts aimed at improving diagnostic capabilities and developing more effective therapeutic agents have been, to date, disappointing in their limited scope and outcomes. Acute cough due to the common cold represents the most common type of cough. Currently, available medications for the symptomatic management of acute cough are inadequate due to lack of proven efficacy and/or their association with undesirable or intolerable side effects at anti-tussive doses. Subacute cough, often representing a prolonged post-viral response, is typically refractory to standard anti-tussive therapy. Few clinical trials have evaluated therapeutic options for subacute cough. Diagnostic challenges facing the clinician in the management of chronic cough include the determination of whether symptoms of upper airway cough syndrome (formerly, postnasal drip syndrome) or gastro-oesophageal reflux disease are indeed the underlying cause of cough. Chronic, refractory unexplained (formerly, idiopathic) cough must be distinguished from cough that has not been fully evaluated and treated according to current guideline recommendations. Eagerly awaited are new safe and effective anti-tussive agents for use when cough suppression is desired, regardless of underlying aetiology of cough, as well as practical, validated ambulatory cough counters to aid clinical assessment and future research in the field of cough.
© 2011 The Author. British Journal of Pharmacology © 2011 The British Pharmacological Society.
Figures
Similar articles
-
Clinical perspective - cough: an unmet need.Curr Opin Pharmacol. 2015 Jun;22:24-8. doi: 10.1016/j.coph.2015.03.001. Epub 2015 Mar 13. Curr Opin Pharmacol. 2015. PMID: 25771118 Review.
-
Pharmacologic therapy for cough.Curr Opin Pharmacol. 2011 Jun;11(3):224-30. doi: 10.1016/j.coph.2011.06.003. Epub 2011 Jul 1. Curr Opin Pharmacol. 2011. PMID: 21724464
-
Currently available antitussives.Pulm Pharmacol Ther. 2009 Apr;22(2):148-51. doi: 10.1016/j.pupt.2008.08.002. Epub 2008 Aug 19. Pulm Pharmacol Ther. 2009. PMID: 18771744 Review.
-
Developing antitussives: the ideal clinical trial.Pulm Pharmacol Ther. 2009 Apr;22(2):155-8. doi: 10.1016/j.pupt.2008.10.012. Epub 2008 Nov 13. Pulm Pharmacol Ther. 2009. PMID: 19041729 Review.
-
Potential new cough therapies.Pulm Pharmacol Ther. 2004;17(6):459-62. doi: 10.1016/j.pupt.2004.09.010. Pulm Pharmacol Ther. 2004. PMID: 15564092 Review.
Cited by
-
Summary of papers presented at the 2012 seventh international cough symposium.Cough. 2013 May 2;9(1):13. doi: 10.1186/1745-9974-9-13. Cough. 2013. PMID: 23639195 Free PMC article.
-
Effect of viral upper respiratory tract infection on cough reflex sensitivity.J Thorac Dis. 2014 Oct;6(Suppl 7):S708-11. doi: 10.3978/j.issn.2072-1439.2013.12.02. J Thorac Dis. 2014. PMID: 25383204 Free PMC article. Review.
-
Chronic cough: more than just a persistent cough: a systematic literature review to understand the impact of chronic cough on quality of life.Qual Life Res. 2024 Apr;33(4):903-916. doi: 10.1007/s11136-023-03556-1. Epub 2023 Dec 28. Qual Life Res. 2024. PMID: 38153616 Review.
-
Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by pro-tussive agents: GRC 17536 as a promising anti-tussive therapeutic.PLoS One. 2014 May 12;9(5):e97005. doi: 10.1371/journal.pone.0097005. eCollection 2014. PLoS One. 2014. PMID: 24819048 Free PMC article.
-
Prevalence of chronic cough in relation to upper and lower airway symptoms; the Skövde population-based study.Front Physiol. 2012 Jul 4;3:251. doi: 10.3389/fphys.2012.00251. eCollection 2012. Front Physiol. 2012. PMID: 22934008 Free PMC article.
References
-
- Adcock JJ. TRPV1 receptors in sensitisation of cough and pain reflexes. Pulm Pharmacol Ther. 2009;22:65–70. - PubMed
-
- Bajbouj M, Becker V, Neuber M, Schmid RM, Meining A. Combined ph-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms. Digestion. 2007;76:223–228. - PubMed
-
- Bangalore S, Kumar S, Messerli FH. Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference. Am J Med. 2010;123:1016–1030. - PubMed
-
- Berry MA, Hargadon B, McKenna S, Shaw D, Green RH, Brightling CE, et al. Observational study of the natural history of eosinophilic bronchitis. Clin Exp Allergy. 2005;35:598–601. - PubMed
-
- Berthet S, Charpiat B, Mabrut JY. Erythromycin as a prokinetic agent: risk factors. J Visc Surg. 2010;147:e13–e18. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical